Shree Renuka Sugars Limited Announces Leadership Changes
Shree Renuka Sugars Limited announced several changes in its leadership structure following a board meeting held on March 11, 2026.Effective April 1, 2026, Mr. Atul Chaturvedi will transition from his current role as Executive Director and Chairman to a Non-Executive Director (Non-Independent). Simultaneously, Mr. Madhu Rao, currently an Independent Director, will assume the position of Chairman of the Board.
The company has also appointed Mr. Susheel Kumar Kamboj as Chief Executive Officer, effective March 23, 2026. Additionally, Mr. Kamboj has been appointed as Managing Director & CEO for a period of five years, also commencing April 1, 2026, pending shareholder approval.
According to company information, Mr. Chaturvedi has extensive experience in the agri-commodities sector and Mr. Rao brings over 30 years of experience from Shangri-La Hotels & Resorts. Mr. Kamboj brings over 20 years of leadership experience across agribusiness, crop protection, seeds, and food sectors.
These changes are subject to shareholder approval via postal ballot.
| Sr. No. | Particulars | Nameof Director: Mr. Madhu Rao (DIN:02683483) |
|---|---|---|
| 1 | Reason for change: Designating Mr. Madhu Rao as Chairman of the Board of Directors | Designating Mr. Madhu Rao (DIN: 02683483), Independent Director, as the Chairman ofthe Board of Directors ofthe Companywith effect from 1' 1 April 2026. |
| 2 | Date and term of appointment | 1 st April 2026 All other terms and conditions of Mr. Rao's appointment as an Independent Director will remain the same. His current term as an Independent Director is for a period of 5 years effective from 27 th June 2023 to 26 th June 2028. |
| Sr. No. | Particulars | Nameof Director: Mr. Susheel Kumar Kamboj (DIN:09531602) |
|---|---|---|
| 1 | Reason for change: Appointment | Appointment of Mr. Susheel Kumar Kamboj as Chief Executive Officer {CEO) and Managing Director (MD) of the Company. |
| 2 | Date and term of appointment | 1. CEO: Appointed w.e.f. 23rd March 2026 2. MD: Appointed as MDfora period of five (5) years commencing from 1st April 2026, not liable to retire by rotation, subject to approval of the shareholders within the prescribed timeline. |
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.